Cynthia Lebeaupin
Company: Pfizer
Job title: Senior Scientist
Seminars:
9:45 am Myeloid Cells Orchestrate Fibrosis in MASH: A Call to Refocus Therapeutic Targeting Beyond Adaptive Immunity 9:45 am
Investigating immune-mediated mechanisms driving fibrosis in MASH, with emphasis on the interplay between innate and adaptive immune cells Identifying myeloid cells as essential architects of the fibrotic niche, promoting bystander T-cell accumulation and activating myofibroblasts Supporting reorienting anti-fibrotic strategies toward targeting innate immune and stromal components, based on integrated analyses from human and preclinical modelsRead more
day: Combination & Sequential Therapy Focus Day
12:30 pm Roundtable Discussion: Synthesizing Novel Mechanisms to Chart the Future of MASH Therapeutic Strategies for Continued Innovation 12:30 pm
Synthesizing learnings from the diverse mechanisms of action presentations for a holistic understanding of MASH pathophysiology to enable the identification of convergent pathways and novel, synergistic drug targets Debating the most promising emerging mechanisms to provide a platform for critical evaluation and prioritization of research efforts for guiding strategic investment, and accelerating the development of…Read more
day: Combination & Sequential Therapy Focus Day